Mirati Therapeutics To Present At Guggenheim Healthcare Talks 2021 Oncology Days
SAN DIEGO, Feb. 4, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced they will participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Oncology Days on Thursday, February 11th at 9:00 a.m. ET/6:00 a.m. PT.Dan Faga, Executive Vice President and Chief Operating Officer, will represent Mirati at the event.